FDA Inspection
ARISTIDES MANIATIS, M.D.ARISTIDES MANIATIS, M.D. – FDA Inspection, Mar 2, 2021
Record Details
This FDA Inspection record concerns ARISTIDES MANIATIS, M.D., with an inspection on March 2, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- ARISTIDES MANIATIS, M.D.
- Inspection Date
- March 2, 2021
- Product Type
- Drugs
View Company Profile
ID · 7d9b72ee-3f14-4d78-9c0f-c5cfbd2d68ec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1136350
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.62(a)Accountability records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of ARISTIDES MANIATIS, M.D.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2022 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for ARISTIDES MANIATIS, M.D.
- FDA Inspection 1187263 - 2022-09-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.